INDIANAPOLIS - Indianapolis-based Eli Lilly and Company is restructuring part of its drug product manufacturing. As a result, up to 100 jobs in central Indiana will be cut. However, those jobs will not be entirely lost, officials said Friday.
Patent expirations were the reason behind the cuts and the changes will take place over the next several years.
Company officials said while jobs will be lost with certain products in the pipeline, there will be new opportunities within the company for new products coming soon.
"This transition will take several years to implement. Employees affected by this plan will have opportunities to move elsewhere within manufacturing, such as our growing insulin and biotechnology areas. As previously announced, Lilly continues to advance insulin-related investments in Indianapolis totaling nearly half a billion dollars to expand insulin active ingredient and drug product manufacturing capacity," a spokesman said in a statement.
Watch RTV6 and refresh this page for updates.
Slain teen's guidance counselor speaks out
For the first time since police announced an arrest in Dominique Allen's killing, her school counselor opened up about their last experiences…
Ind. woman drops 60 lbs. to give husband kidney
This Thanksgiving, an Indiana man was thankful for the chance to get well -- all thanks to his wife who had to improve her health first.
Wal-Mart releases images of suspected robbers
A Wal-Mart store on the city's north side released surveillance images Tuesday evening after store greeters were reportedly held at gunpoint.
Man killed in shooting on city's west side
A person was killed in a shooting on the city's west side Tuesday evening.
FBI: Probe of Hammond stun gun stop not over
A northwestern Indiana mayor says two officers will immediately return to street duty after the city learned the FBI has closed its…
WATCH: Circle of Lights Talent Search
Nearly 150 singers, musical groups and dancers auditioned for their chance to perform at the 52nd annual Circle of Lights.